• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化斑块中的纤维蛋白沉积和纤维蛋白降解产物

Fibrin deposition and fibrin degradation products in atherosclerotic plaques.

作者信息

Smith E B

机构信息

Department of Clinical Biochemistry, University of Aberdeen, Foresterhill, Scotland.

出版信息

Thromb Res. 1994 Aug 1;75(3):329-35. doi: 10.1016/0049-3848(94)90246-1.

DOI:10.1016/0049-3848(94)90246-1
PMID:7992244
Abstract

Soluble fibrin/fibrinogen-related antigens and insoluble fibrin are present in virtually all samples of human aortic intima. Components of the soluble fraction were identified by SDS-PAGE and immunoblotting with specific antisera. The fibrinogen was characterized by increased proportions of low molecular mass (Mr) species (300 and 280 kD), the FDP by fragments DY and DD derived from crosslinked fibrin, and by fragment E that lacked fibrinopeptide A (FPA). Experiments suggest that fibrin is formed in situ, and free thrombin was present in all 10 samples analysed for prothrombin-related antigen (PtRA). Fibrin-derived fragment E is mitogenic, so fibrin degradation may provide continuing stimulation of smooth muscle cell (SMC) proliferation.

摘要

可溶性纤维蛋白/纤维蛋白原相关抗原和不溶性纤维蛋白几乎存在于所有人主动脉内膜样本中。通过SDS-PAGE和用特异性抗血清进行免疫印迹鉴定了可溶性部分的成分。纤维蛋白原的特征是低分子量(Mr)种类(300和280 kD)的比例增加,FDP的特征是来自交联纤维蛋白的片段DY和DD,以及缺乏纤维蛋白肽A(FPA)的片段E。实验表明纤维蛋白是原位形成的,并且在所有10个分析凝血酶原相关抗原(PtRA)的样本中都存在游离凝血酶。纤维蛋白衍生的片段E具有促有丝分裂作用,因此纤维蛋白降解可能会持续刺激平滑肌细胞(SMC)增殖。

相似文献

1
Fibrin deposition and fibrin degradation products in atherosclerotic plaques.动脉粥样硬化斑块中的纤维蛋白沉积和纤维蛋白降解产物
Thromb Res. 1994 Aug 1;75(3):329-35. doi: 10.1016/0049-3848(94)90246-1.
2
[Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Rinsho Byori. 1990 Feb;38(2):201-7.
3
Fate of fibrinogen in human arterial intima.纤维蛋白原在人体动脉内膜中的命运
Arteriosclerosis. 1990 Mar-Apr;10(2):263-75. doi: 10.1161/01.atv.10.2.263.
4
Prothrombin-related antigens in human aortic intima.
Semin Thromb Hemost. 1996;22(4):347-50. doi: 10.1055/s-2007-999030.
5
Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies.动脉粥样硬化中纤维蛋白原、纤维蛋白及纤维蛋白(原)降解产物的鉴定与分布。单克隆抗体的应用。
Arteriosclerosis. 1989 Jan-Feb;9(1):109-21. doi: 10.1161/01.atv.9.1.109.
6
Atherosclerotic plaque growth: presence of stimulatory fibrin degradation products.
Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):489-93.
7
[Effects of fibrinogen, fibrin and their degradation products on the behaviour of vascular smooth muscle cells].[纤维蛋白原、纤维蛋白及其降解产物对血管平滑肌细胞行为的影响]
Nihon Ronen Igakkai Zasshi. 2000 Jun;37(6):458-63. doi: 10.3143/geriatrics.37.458.
8
The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.锯鳞蝰蛇咬伤后可溶性纤维蛋白复合物和纤维蛋白降解产物的结构
Br J Haematol. 1980 Mar;44(3):471-81. doi: 10.1111/j.1365-2141.1980.tb05917.x.
9
Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis.纤维蛋白降解产物刺激平滑肌细胞生长。纤维蛋白片段E在再狭窄和动脉粥样硬化形成中的潜在作用。
Thromb Res. 2000 Apr 15;98(2):165-74. doi: 10.1016/s0049-3848(99)00202-9.
10
[Differentiation of fibrinolysis and fibrinogenolysis by analysis of FDP fragments].通过FDP片段分析鉴别纤维蛋白溶解和纤维蛋白原溶解
Rinsho Byori. 1992 Jul;40(7):789-94.

引用本文的文献

1
Pharmacological targeting of coagulation factor XI mitigates the development of experimental atherosclerosis in low-density lipoprotein receptor-deficient mice.凝血因子XI的药理学靶向作用可减轻低密度脂蛋白受体缺陷小鼠实验性动脉粥样硬化的发展。
J Thromb Haemost. 2021 Apr;19(4):1001-1017. doi: 10.1111/jth.15236. Epub 2021 Feb 10.
2
Fusigen Reduces Intracellular Reactive Oxygen Species and Nitric Oxide Levels.融合素降低细胞内活性氧和一氧化氮水平。
In Vivo. 2019 Mar-Apr;33(2):425-432. doi: 10.21873/invivo.11490.
3
Oxidation inhibits iron-induced blood coagulation.
氧化抑制铁诱导的血液凝固。
Curr Drug Targets. 2013 Jan 1;14(1):13-9. doi: 10.2174/1389450111314010003.
4
Hydroxyl radical and its scavengers in health and disease.羟基自由基及其在健康和疾病中的清除剂。
Oxid Med Cell Longev. 2011;2011:809696. doi: 10.1155/2011/809696. Epub 2011 Jul 17.
5
Mechanisms of fibrinogen-induced microvascular dysfunction during cardiovascular disease.纤维蛋白原在心血管疾病期间导致微血管功能障碍的机制。
Acta Physiol (Oxf). 2010 Jan;198(1):1-13. doi: 10.1111/j.1748-1716.2009.02037.x. Epub 2009 Sep 1.
6
Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.影响高血压同胞血浆炎症标志物水平的基因组区域。
J Hum Hypertens. 2008 Feb;22(2):102-10. doi: 10.1038/sj.jhh.1002297. Epub 2007 Oct 25.
7
Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.在纤溶酶原激活物抑制剂-1完全缺乏的小鼠中,铜诱导损伤后血管壁的重塑显著减弱。
Am J Pathol. 2001 Jan;158(1):107-17. doi: 10.1016/S0002-9440(10)63949-1.
8
Plasminogen deficiency accelerates vessel wall disease in mice predisposed to atherosclerosis.纤溶酶原缺乏会加速易患动脉粥样硬化小鼠的血管壁疾病。
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10335-40. doi: 10.1073/pnas.94.19.10335.